There were two interesting ECJ rulings in the first quarter of 2025: one concerned the use of botanicals on hold, specifically the issue of which transition periods apply to which type of claims (keyword: saffron/psycho claims). In the second ECJ ruling, it was determined that mannose is not permitted in a medical device: according to the ECJ, mannose has a pharmacological effect.